We are live on ! Find out more
ALT icon

Altimmune
ALT

143 hedge funds and large institutions have $389M invested in Altimmune in 2023 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

391% more capital invested

Capital invested by funds: $79.2M → $389M (+$310M)

124% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 25

71% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 24

66% more call options, than puts

Call options by funds: $32M | Put options by funds: $19.3M

28% more funds holding

Funds holding: 112 → 143 (+31)

6.79% more ownership

Funds ownership: 57.53% → 64.32% (+6.8%)

Holders
143
Holders Change
+31
Holders Change %
+27.68%
% of All Funds
2.08%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
56
Increased
41
Reduced
24
Closed
25
Calls
$32M
Puts
$19.3M
Net Calls
+$12.8M
Net Calls Change
+$11.5M

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$17.4M
2
Morgan Stanley
Morgan Stanley
New York
+$6.67M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.2M
4
TIM
Timelo Investment Management
Ontario, Canada
+$3.25M
5
Invesco
Invesco
Georgia
+$2.98M

Top Sellers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
-$7.18M
2
Marshall Wace
Marshall Wace
United Kingdom
-$7.15M
3
APM
Avidity Partners Management
Texas
-$3.02M
4
AAP
Ardsley Advisory Partners
Connecticut
-$2.72M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
GL
26
Gerber LLC
Ohio
$2.88M +$1.07M +255,778 New
JFG
27
Jefferies Financial Group
New York
$2.43M +$902K +216,000 New
GCP
28
GSA Capital Partners
United Kingdom
$2.36M -$987K -236,406 -53%
SPS
29
Susquehanna Portfolio Strategies
Pennsylvania
$2.33M +$865K +207,197 New
KCM
30
Knoll Capital Management
Florida
$2.25M +$835K +200,000 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$2.16M +$52.9K +12,681 +7%
Millennium Management
32
Millennium Management
New York
$1.96M +$321K +76,908 +79%
SAM
33
Sectoral Asset Management
Quebec, Canada
$1.92M +$713K +170,800 New
SCM
34
Silverarc Capital Management
Massachusetts
$1.69M +$626K +150,000 New
CSS
35
Cubist Systematic Strategies
Connecticut
$1.63M +$413K +98,832 +214%
Charles Schwab
36
Charles Schwab
California
$1.61M +$38.9K +9,310 +7%
SSA
37
Schonfeld Strategic Advisors
New York
$1.52M +$564K +135,000 New
IMC Chicago
38
IMC Chicago
Illinois
$1.48M +$550K +131,738 New
DA
39
DCF Advisers
Connecticut
$1.3M -$19.8K -4,750 -4%
Squarepoint
40
Squarepoint
New York
$1.27M +$471K +112,773 New
GS
41
Gagnon Securities
New York
$1.25M -$752 -180 -0.2%
PI
42
Pennant Investors
New Jersey
$1.24M +$458K +109,800 New
QOP
43
Quinn Opportunity Partners
Virginia
$1.18M +$438K +105,000 New
SAM
44
Silvercrest Asset Management
New York
$1.16M – – –
CCM
45
Callodine Capital Management
Massachusetts
$1.13M +$418K +100,000 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$1.03M +$349K +83,701 +998%
JP Morgan Chase
47
JP Morgan Chase
New York
$1.02M +$127K +30,467 +51%
Marshall Wace
48
Marshall Wace
United Kingdom
$969K -$7.15M -1,712,608 -95%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$916K +$16.9K +4,051 +5%
BWM
50
Brown Wealth Management
Illinois
$844K +$313K +75,000 New
1
2
3 4 5

ALT Hedge Fund Activity: Q4 2023 in Review

143 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2023, worth a combined $389M — up 391% from $79.2M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new ALT positions and 25 closed out — a net gain of 31 holders — while 41 added to existing stakes and 24 trimmed.

The largest buyer was Ameriprise, adding an estimated $17.4M. The largest seller was Nuveen, cutting an estimated $7.18M.

  • 143 institutional investors held Altimmune (ALT) as of Q4 2023, up from 112 in Q3 2023.
  • Funds reported $389M of Altimmune stock for Q4 2023, up 391% quarter-over-quarter.
  • 56 funds opened new Altimmune positions in Q4 2023 and 25 closed out, a net change of +31 holders.
  • The largest Altimmune buyer in Q4 2023 was Ameriprise, an estimated $17.4M added.
  • The largest Altimmune seller in Q4 2023 was Nuveen, an estimated $7.18M sold.

Based on aggregated 13F filings for Q4 2023.